PS
Prachi Sushil Mahimkar
About Prachi Sushil Mahimkar
Data last updated:
Prachi Sushil Mahimkar is a Director at Romek Lifesciences Private Limited (since 2023) and Director at Romek Commercials Private Limited (since 2023). The companies operate in Pharma. The largest current company by reported revenue is Romek Lifesciences Private Limited at ₹26.56 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Jun 2023 | 2023 | ₹26.56 Cr (FY 2025) | Active | |
| Director | 28 Mar 2023 | 2023 | Active |
Board colleagues of Prachi Sushil Mahimkar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pushpalata Vijay Pawar | 10210994 | Romek Lifesciences Private Limited , Romek Commercials Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prachi Sushil Mahimkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prachi Sushil Mahimkar
Prachi Sushil Mahimkar currently holds 2 directorships: Romek Lifesciences Private Limited (Director, since 22 Jun 2023, revenue ₹26.56 Cr (FY 2025)); Romek Commercials Private Limited (Director, since 28 Mar 2023).
Prachi Sushil Mahimkar was first appointed on 28 Mar 2023 as Director at Romek Commercials Private Limited.
The current boards of Prachi Sushil Mahimkar's companies include Pushpalata Vijay Pawar (Romek Lifesciences Private Limited).